Skip to main content
. 2020 Jan 22;11:2042018819897527. doi: 10.1177/2042018819897527

Figure 2.

Figure 2.

Obesity-induced changes in pharmacokinetic properties of drugs.

In obese patients, pharmacokinetic drug properties are altered (arrows indicating: ↑↓ indifferent, ↑ increased, ↓ decreased capacity). Consequently, resulting drug concentration at the place of action and pharmacologic effect might be different to normal weight patients.